Analyst consensus rating
Coya Therapeutics Analyst Rating: Strong Buy
Direct answer
Coya Therapeutics's consensus rating is Strong Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $15.21.
Forecast evidence checked November 14, 2026.
Get free Coya Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.13
- Average price target
- $15.21
- High price target
- $18.00
- Low price target
- $12.00
- Low target gap
- +283.4%
- Target upside
- +386.1%
- High target gap
- +475.1%
- Target range width
- 191.7%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Coya Therapeutics?
Coya Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $15.21.
How far are Coya Therapeutics's low and high targets from the recorded price?
The low target implies +283.4%, while the high target implies +475.1%.
How many analysts are included in Coya Therapeutics's consensus?
The verified consensus includes 7 analysts.
How is Coya Therapeutics's target upside or downside calculated?
The average target of $15.21 is divided by the recorded price of $3.13, then one is subtracted to produce +386.1%. This does not guarantee a future return.
When was Coya Therapeutics's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.